Aurobindo Pharma’s wholly owned step-down subsidiary -- Lannett Company LLC has received four observations, which are procedural in nature, from The United States Food and Drug Administration (USFDA). The USFDA conducted a routine inspection at Lannett Company LLC, located at Seymour, IN, USA from August 17 to August 21, 2026.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
